Leptin Receptor Deficiency Obesity

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-05-23
Clinical Trial Update: Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity [Phase 3]
Phase 3 trial evaluating setmelanotide for leptin receptor deficiency obesity has completed with results posted.